Analystreport

Cytokinetics, Inc. (NASDAQ: CYTK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating on the stock.

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview